Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 54
- Hemp Industry
UK Drugs Watchdog Recommends 0.3% THC Limit for Hemp, Marking ‘Very Material Step Forward’ For Industry
Last week, the UK’s Advisory Council on the Misuse of Drugs published an official recommendation that the THC limit on industrial hemp should be raised to 0.3%, bringing it in line with the EU.
- Uncategorized
Managers of New York’s Troubled Cannabis Social Equity Loan Scheme to Pocket Millions Despite Failures
New York’s Cannabis Social Equity Investment Fund has so far failed to achieve its intended goal of raising $200m from a combination of public and private investment and helping 150 businesses open up across the state.
- Companies
Bedrocan Expands into Denmark with New High-CBD Cannabis Strain for Medical Use
Bedrocan, one of Europe’s largest and longest-running suppliers of pharmaceutical and medical cannabis, has announced plans to commercialise a new high-CBD strain of cannabis, Bedrolina.
- Uncategorized
New York Fines Illegal Cannabis Store Operator Nearly $10m in Warning to Illicit Market
An unlicensed cannabis store in New York has been fined nearly $10m under the state’s ongoing campaign to quash its rampant illicit market.
- Uncategorized
Legal Campaign to Overturn Federal Cannabis Prohibition Gets Oral Arguments Date in ‘Great News’ for Plaintiffs
Ongoing legal efforts to overturn the federal prohibition of cannabis received a welcome boon this week, as the appeals court scheduled a date for oral arguments to take place.
- Markets & Stocks
Little Green Pharma Stock Flies Amid Record Quarter, & Althea Sells UK Subsidiary
Little Green Pharma [stock_market_widget type=”chart” template=”line” assets=”LGP.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Australian Stock Exchange (ASX) listed medical cannabis firm Little Green Pharma (LGP) saw its stock rally by over 60% this week after reporting record revenues.
- Medical
The Untapped Potential: How UK Medical Cannabis Prescriptions are Growing but Missing Millions
Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the public still lags behind.
- Uncategorized
Arkansas Supreme Court Cancels Upcoming Vote on Medical Cannabis Expansion
The Arkansas State Supreme Court has voted to dismiss an upcoming vote on the expansion of the state’s medical cannabis program, just weeks before the vote was due.
- Uncategorized
Young US Women Overtake Men in Cannabis Consumption for the First Time, and Retailers Are Rethinking Their Strategies
Young US women are consuming more cannabis than men for the first time, according to recently published data from the US National Institute on Drug Abuse (NIDA).
- Press releases
Medical cannabis could save NHS £4 billion each year
Allowing medical cannabis to be prescribed on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually, according to a new research study.
- Medical
France Proposes Budget Amendment in Last-Ditch Effort to Keep Medical Cannabis Programme Alive
A proposal has been tabled in France aimed at further extending the country’s long-running medical cannabis ‘experiment’ to ensure patients are able to keep receiving their medication amid government inaction.
- Uncategorized
3 out of 4 US Cannabis Reform Bills Expected to Pass This November
November is set to be a critical month for cannabis legalization efforts in the US, with four states placing key cannabis reforms on the ballot.












